APA (7th ed.) Citation

Jang, H., & Chang, J. (2025). Strategic Combinations of Antibody–Drug Conjugates from 2023 to 2025: From Dual Therapies to Innovative ADC-Based Regimens. Pharmaceutics, 17(12), 1581. https://doi.org/10.3390/pharmaceutics17121581

Chicago Style (17th ed.) Citation

Jang, Heewon, and Ji-Eun Chang. "Strategic Combinations of Antibody–Drug Conjugates from 2023 to 2025: From Dual Therapies to Innovative ADC-Based Regimens." Pharmaceutics 17, no. 12 (2025): 1581. https://doi.org/10.3390/pharmaceutics17121581.

MLA (9th ed.) Citation

Jang, Heewon, and Ji-Eun Chang. "Strategic Combinations of Antibody–Drug Conjugates from 2023 to 2025: From Dual Therapies to Innovative ADC-Based Regimens." Pharmaceutics, vol. 17, no. 12, 2025, p. 1581, https://doi.org/10.3390/pharmaceutics17121581.